9.38
price up icon2.51%   +0.23
 
loading

Zymeworks Inc. (ZYME) 最新ニュース

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME) - Business Wire

pulisher
Business Wire

Zymeworks BC Inc (ZYME) deserves deeper analysis – US Post News - US Post News

pulisher
US Post News

Taking a Closer Look At Zymeworks BC Inc (ZYME) Following Its Recent Trade – Knox Daily - Knox Daily

pulisher
Knox Daily

Zymeworks (ZYME) Stock Forecast and Price Target 2024 - MarketBeat

pulisher
MarketBeat

Zymeworks (NYSE:ZYME) Rating Reiterated by HC Wainwright - Defense World

pulisher
Defense World

Zymeworks (NYSE:ZYME) Rating Reiterated by HC Wainwright - Defense World

pulisher
Defense World

Zymeworks Inc. (ZYME) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Movies UK

pulisher
Yahoo Movies UK

Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

pulisher
Benzinga

Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Zymeworks (NASDAQ:ZYME) - Benzinga

pulisher
Benzinga

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME - PR Newswire

pulisher
PR Newswire

Take off with Zymeworks BC Inc (ZYME): Get ready for trading – Sete News - SETE News

pulisher
SETE News

How Much Upside is Left in Zymeworks Inc. (ZYME)? Wall Street Analysts Think 65.75% - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Zymeworks (NYSE:ZYME) PT Lowered to $12.00 at Wells Fargo & Company - Defense World

pulisher
Defense World

Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

pulisher
Yahoo Finance

Zymeworks First Quarter 2024 Earnings: Misses Expectations - Simply Wall St

pulisher
Simply Wall St

Earnings call: Zymeworks outlines clinical strategy and financial health - Investing.com

pulisher
Investing.com

Zymeworks Inc.'s (NASDAQ:ZYME) Shares Lagging The Industry But So Is The Business - Simply Wall St

pulisher
Simply Wall St

Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research

pulisher
Zacks Investment Research

Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

Zymeworks Touts Financial Health and R&D Progress - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Inc Stresses Transparency in Investor Communications - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Finance

pulisher
Yahoo Finance

Zymeworks Engages in Key Investor Conferences - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire

pulisher
GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

pulisher
GlobeNewswire Inc.

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire

pulisher
GlobeNewswire

Buy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Data (NASDAQ:ZYME) - Seeking Alpha

pulisher
Seeking Alpha

Zymeworks Announces Upcoming Financial Report - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

pulisher
GlobeNewswire Inc.

Zymeworks (ZYME) Loses -13.41% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

pulisher
Zacks Investment Research

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

pulisher
GlobeNewswire Inc.

Zymeworks Unveils Promising Cancer Research - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks CFO Dr. Astle Exits with Severance Package - TipRanks.com - TipRanks

pulisher
TipRanks

ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks ... - GlobeNewswire

pulisher
GlobeNewswire

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME) - GlobeNewswire

pulisher
GlobeNewswire

Zymeworks appoints interim CFO after sudden removal By Investing.com - Investing.com

pulisher
Investing.com

Zymeworks Inc. Strengthens Board with Dr. Gallagher's Appointment - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

pulisher
GlobeNewswire Inc.

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors - Yahoo Finance

pulisher
Yahoo Finance

Zymeworks Engages Investors in April Conferences - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Announces Participation in Upcoming Investor Conferences

pulisher
GlobeNewswire Inc.

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire

pulisher
GlobeNewswire

Zymeworks (ZYME) Upgraded to Buy: What Does It Mean for the Stock?

pulisher
Zacks Investment Research

Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

pulisher
GlobeNewswire Inc.

Zymeworks Poised for Growth with Strong Cash Position - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks Highlights Cancer Therapeutics at AACR - TipRanks.com - TipRanks

pulisher
TipRanks

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

pulisher
GlobeNewswire Inc.

Zymeworks: A Strong Buy Amidst Zanidatamab's Promising Developments (NASDAQ:ZYME) - Seeking Alpha

pulisher
Seeking Alpha
$76.97
price down icon 4.27%
$151.22
price up icon 2.59%
$29.65
price down icon 1.89%
$171.03
price up icon 3.73%
$376.60
price down icon 0.10%
$92.98
price up icon 0.85%
大文字化:     |  ボリューム (24 時間):